Picture of Larimar Therapeutics logo

LRMR — Larimar Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

Brief: Larimar Therapeutics Q4 Net Income USD -28.824 Million

Mar 24 (Reuters) - Larimar Therapeutics Q4 operating expenses USD 31.293 million.

Q4 basic EPS USD -0.45

Q4 income from operations USD -31.293 million

Recent news on Larimar Therapeutics

See all news